Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it.
Last month, the Food and Drug Administration approved Moderna’s mFLUSIVA for adults 50 and older. In a large Phase 3 trial, the vaccine was almost 27% more effective than a standard flu shot at preventing lab-confirmed influenza.
That’s especially welcome news after one of the worst flu seasons in years. It’s also arriving at a strange moment for the technology behind it.
Labor market Albert Lea Tribune: Minnesota jobs stable over the month and grew…
2025 is an off-year for elections in Minnesota, except for the municipal…
The Educational Choice for Children Act (ECCA) represents a major shift in how…
When Dr. Tabia Lee was hired by De Anza College to lead its Office of Equity,…
There are 9,081 fewer students enrolled in Chicago Public Schools, driven…
Yesterday, I wrote about Minnesota’s performance on the raw labor components of…
I’m working to update ScandalTrackerTM, which has not been refreshed since July.…
The United States of America is in a crisis. For nearly five decades our nation…
Later today, Minnesota Management & Budget (MMB) is due to release its…
Connecticut residents don’t need to wait for their next utility bill to know…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.
